aptivus

Generic: tipranavir

Labeler: boehringer ingelheim pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name aptivus
Generic Name tipranavir
Labeler boehringer ingelheim pharmaceuticals, inc.
Dosage Form CAPSULE, LIQUID FILLED
Routes
ORAL
Active Ingredients

tipranavir 250 mg/1

Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 0597-0003
Product ID 0597-0003_089edede-222a-4895-ac85-82b775ef3352
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021814
Listing Expiration 2026-12-31
Marketing Start 2005-07-01

Pharmacologic Class

Established (EPC)
protease inhibitor [epc]
Mechanism of Action
hiv protease inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 05970003
Hyphenated Format 0597-0003

Supplemental Identifiers

RxCUI
577212 603378
UNII
ZZT404XD09
NUI
N0000000246 N0000175889

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aptivus (source: ndc)
Generic Name tipranavir (source: ndc)
Application Number NDA021814 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02)
source: ndc

Packages (1)

0597-0003-02 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02)

Ingredients (1)

tipranavir (250 mg/1)

Linked Drug Pages (1)

Aptivus ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "089edede-222a-4895-ac85-82b775ef3352", "openfda": {"nui": ["N0000000246", "N0000175889"], "unii": ["ZZT404XD09"], "rxcui": ["577212", "603378"], "spl_set_id": ["08982e49-d2eb-4b25-b01a-1be52fd669ef"], "pharm_class_epc": ["Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0597-0003-02)", "package_ndc": "0597-0003-02", "marketing_start_date": "20050701"}], "brand_name": "Aptivus", "product_id": "0597-0003_089edede-222a-4895-ac85-82b775ef3352", "dosage_form": "CAPSULE, LIQUID FILLED", "pharm_class": ["HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "0597-0003", "generic_name": "tipranavir", "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aptivus", "active_ingredients": [{"name": "TIPRANAVIR", "strength": "250 mg/1"}], "application_number": "NDA021814", "marketing_category": "NDA", "marketing_start_date": "20050701", "listing_expiration_date": "20261231"}